Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma (Q47894197)

6 February 2018

title

Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma (English)

1 reference

6 February 2018

author name string

C Damgé

series ordinal

1

1 reference

6 February 2018

A Hajri

series ordinal

2

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

6 February 2018

European Journal of Pharmacology

published in

1 reference

6 February 2018

volume

347

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

77-86

1 reference

6 February 2018

Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Bombesin stimulates the in vitro growth of a human gastric cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Direct effect of bombesin on pancreatic and gastric growth in suckling rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Binding properties of somatostatin receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Mechanisms of bombesin on growth of gastrinoma (PT) in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Receptor-specific somatostatin analogs: correlations with biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Comparative effect of chronic bombesin, gastrin-releasing peptide and caerulein on the rat pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Techniques for measuring amylase secretion from pieces of mouse pancreas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Effect of prolonged administration of long-acting somatostatin on caerulein, CCK-8 and GRP induced pancreatic growth in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Progress in the development of potent bombesin receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Trophic effect of bombesin on the rat pancreas: is it mediated by the release of gastrin or cholecystokinin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Evidence for a direct trophic effect of bombesin on the mouse pancreas: in vivo and cell culture studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Synergistic effects of bombesin and epidermal growth factor on cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Pancreatic carcinoma in azaserine-treated rats: induction, classification and dietary modulation of incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Effects of sandostatin and castration on pancreatic carcinogenesis in rats and hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Somatostatin: a potential antigrowth factor for the exocrine pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

[ON THE DETERMINATION OF TRYPSIN AND CHYMOTRYPSIN WITH AMINO-P-NITROANILIDES]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Somatostatin and somatostatin analogues in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM23014.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Multiple actions of somatostatin in neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Effects of the somatostatin analog BIM 23014 on the secretion of growth hormone, thyrotropin, and digestive peptides in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900088-0

10.1016/S0014-2999(98)00088-0

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9650851

1 reference

6 February 2018